Live Analyst Rating Changes 22261 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/David Rescott
BAIRD

David Rescott

Wall Street Analyst
★★★☆☆
#1069
on 13Foresight · ranked by our own returns
61%
Success Rate
+3.1%
Average Return
19 of 31 calls profitable · -1.9% vs benchmark
S&P 500 (SPY)
🔒 5-year track record is Pro. Showing 1-year — upgrade.
📈 Across the calls we could measure, roughly 61% of David Rescott's ratings turned a profit when each position was held for 1 year — averaging +3.1% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

40 Buy 26 Hold 0 Sell
David's Stock Coverage 20 ratings · 2026-08-10
Company Date Position Consensus Price Target 1-Yr Return vs S&P 500
IRTC
Irhythm Technologies
Aug 07, 2026 BUY Strong Buy
+31.0% avg upside
20 analysts
$165.00
29.01% Upside
· ·
RMD
Resmed
Aug 07, 2026 HOLD Buy
+7.1% avg upside
27 analysts
$213.00
0.47% Upside
+0.0% ·
HAE
Haemonetics
Aug 07, 2026 BUY Buy
-14.2% avg upside
17 analysts
$96.00
9.38% Upside
+0.0% ·
NYXH
Nyxoah
Aug 06, 2026 HOLD Strong Buy
+844.2% avg upside
12 analysts
$2.31
57.07% Upside
+12.2% ·
TMDX
TransMedics Group
Aug 05, 2026 BUY Strong Buy
+21.3% avg upside
15 analysts
$122.00
45.43% Upside
+7.6% ·
PRCT
PROCEPT BioRobotics
Aug 05, 2026 HOLD Buy
+54.7% avg upside
17 analysts
$20.00
1.99% Downside
+9.8% ·
INSP
Inspire Medical Systems
Aug 04, 2026 HOLD Buy
+40.7% avg upside
21 analysts
$59.00
1.89% Downside
-6.2% ·
MMSI
Merit Medical Systems
Jul 31, 2026 BUY Strong Buy
+10.6% avg upside
15 analysts
$98.00
10.12% Upside
+4.7% ·
BSX
Boston Scientific
Jul 30, 2026 BUY Strong Buy
+36.5% avg upside
38 analysts
$56.00
13.63% Upside
+7.2% ·
HTFL
HeartFlow, Inc.
Jul 30, 2026 BUY Strong Buy
+25.6% avg upside
9 analysts
$34.00
17.91% Upside
+13.6% ·
ISRG
Intuitive Surgical
Jul 17, 2026 BUY Strong Buy
+26.0% avg upside
36 analysts
$500.00
31.90% Upside
+13.9% ·
ABT
Abbott Laboratories
Jun 30, 2026 BUY Strong Buy
+6.7% avg upside
36 analysts
$121.00
12.29% Upside
+20.6% ·
MDT
Medtronic
Jun 04, 2026 HOLD Buy
+10.2% avg upside
38 analysts
$85.00
2.38% Downside
+7.3% ·
LIVN
LivaNova
May 07, 2026 BUY Strong Buy
+6.7% avg upside
15 analysts
$76.00
0.26% Downside
+7.5% ·
EW
Edwards Lifesciences
Apr 24, 2026 HOLD Strong Buy
+11.5% avg upside
34 analysts
$87.00
3.02% Downside
+10.3% ·
PEN
Penumbra
Jan 15, 2026 HOLD Buy
+1.7% avg upside
23 analysts
$374.00
15.19% Upside
-7.1% ·
L
Loews
Apr 24, 2025 HOLD Strong Buy
-57.5% avg upside
5 analysts
+28.5% ·
SIBN
SI-Bone
Feb 28, 2023 BUY Strong Buy
+38.6% avg upside
18 analysts
$26.00
39.67% Upside
-12.2% ·
ZBH
Zimmer Biomet Holdings
Dec 21, 2021 BUY Buy
+17.5% avg upside
38 analysts
$145.00
50.16% Upside
+7.8% ·
KIDS
OrthoPediatrics
Dec 21, 2021 BUY Strong Buy
+37.1% avg upside
10 analysts
$75.00
229.44% Upside
-34.2% ·
🔒 15 more ratings — with price targets, crowd consensus and our measured returns.
Free account unlocks every analyst's full coverage table.
David Rescott — Frequently Asked Questions
How accurate are David Rescott's stock ratings?
Based on the calls 13Foresight could measure, about 61% of David's ratings were profitable over a one-year hold, with an average return of +2.9% per rating, or -2.2% versus the S&P 500. We score every analyst the same way, from historical prices. Each return is measured in the stock's own trading currency, so for non-US listings the S&P 500 comparison leaves out currency moves.
How is David ranked on 13Foresight?
David Rescott is currently ranked #1069 with a 3-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does David cover?
David most recently has ratings on IRTC, RMD, HAE, NYXH, TMDX, PRCT, INSP, MMSI, BSX, HTFL, ISRG, ABT and 8 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.